---
title: "Facing doubts about raw material components again, GIANT BIOGENE responded: Multiple batch test results show collagen is greater than 0.1%"
description: "GIANT BIOGENE's brand KefuMei issued a statement in response to social media influencers questioning the collagen content in its restructuring products, stating that multiple batches of test results s"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/241722786.md"
published_at: "2025-05-24T23:41:11.000Z"
---

# Facing doubts about raw material components again, GIANT BIOGENE responded: Multiple batch test results show collagen is greater than 0.1%

> GIANT BIOGENE's brand KefuMei issued a statement in response to social media influencers questioning the collagen content in its restructuring products, stating that multiple batches of test results show collagen content greater than 0.1%. The test reports indicate that the collagen content of the samples was 0.27%, 0.27%, and 0.28%, respectively. KefuMei also stated that it has commissioned an authoritative third-party organization for further testing and will promptly announce the results

On May 24th, a social media influencer with 430,000 followers posted a video and text post titled "GIANT BIOGENE suspected of fraud: Reconstructed collagen cannot be detected!" On the evening of May 24th, the brand KefuMei under GIANT BIOGENE released a "Stern Statement - Notice to Consumers" on its official social media account. In the statement, KefuMei responded to the core issue: "At the first moment the incident occurred, we conducted tests on the relevant products according to the 'Pharmacopoeia of the People's Republic of China' and other relevant industry standards, and multiple batches of test results showed that the collagen content was greater than 0.1%." Additionally, the account published a "Testing Report of Xi'an GIANT BIOGENE Technology Co., Ltd." which showed that on May 24th, five samples were taken to test for collagen content. The test results were 0.27%, 0.27%, and 0.28%, respectively. Furthermore, the statement mentioned that multiple authoritative third-party testing institutions have been commissioned to conduct further tests on the relevant products using various testing methods, and the results will be announced as soon as possible. Regarding the influencer's testing method, KefuMei responded: "It is not included in the relevant industry standards and has not undergone rigorous methodological validation. At the same time, the influencer has not requested the company for the raw materials of the reconstructed collagen."

### Related Stocks

- [02367.HK - GIANT BIOGENE](https://longbridge.com/en/quote/02367.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 早盘趋势｜巨子生物多头信心松动，关键支撑岌岌可危？ | 1 月 27 日，巨子生物（2367.HK）盘中弱势震荡，盘面反复探底，多次试探 28 元整数关口支撑未果。全天资金持续流出，绿盘成交占比高，显示多头信心逐步松动，主力持仓筹码开始松懈。 生物科技板块过去一周受地方政策分歧影响，持续表现低迷 | [Link](https://longbridge.com/en/news/273815223.md) |
| 华尔街大佬 Tepper 押注 AI：美光持仓激增 200%，新买韩国 ETF | 对冲基金大佬 Tepper 去年四季度精准狙击 AI 芯片赛道，豪掷逾 6 亿美元重仓美光科技和韩国芯片 ETF，今年已斩获约 30% 回报。全球内存短缺叠加 AI 算力狂潮，其芯片押注与软件股暴跌形成冰火两重天。 | [Link](https://longbridge.com/en/news/276213747.md) |
| 美股的 “危险信号” | 本月标普 500 指数成分股在八个交易日内下跌 7% 或以上的股票数量已经超过 100 只，直逼 2022 年美股熊市的水平。 虽然这不像新冠疫情或关税危机期间那样极端，但该指标超过 100 通常意味着更大范围的下滑，而这种情况目前还没有发 | [Link](https://longbridge.com/en/news/276185288.md) |
| 特朗普阵营的坚定降息派动摇了？美联储理事米兰：劳动力市场改善可令今年少些降息 | 坚定降息派、特朗普亲信美联储理事米兰：美国劳动力市场的改善可以令今年少些降息。风险提示及免责条款 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何意见、观点或结论是否符 | [Link](https://longbridge.com/en/news/276386713.md) |
| 美油大涨 5%！美以或对伊朗联合袭击，白宫称谈判取得进展、但关键议题相距甚远 | 周三，报道称，美以或将对伊朗发动联合袭击。白宫表示，美伊谈判取得进展，但在关键议题上相距甚远。以官员称，美对伊发动军事打击的 “时间表正在缩短”。伊朗方面预计将在未来几周内提交更具体方案，特朗普将继续评估谈判进展。WTI 原油盘中涨幅一度达 | [Link](https://longbridge.com/en/news/276276692.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.